Replay available

GeneDx Holdings Corp. (WGS) Q4 2025 Earnings Call

GeneDx Holdings Corp. (NASDAQ: WGS) Q4 2025 earnings conference call, held 2026-02-23. Replay captured from the company's public earnings webcast.

Mon, February 23, 2026 at 8:30 AMendedReplay
GeneDx Holdings Corp. (WGS) Q4 2025 Earnings Call

Investor webinar replay

Latest press releases

Companies on this event

Featured Presenters

Sabrina Dunbar

Investor Relations

Catherine Stuland

President & Chief Executive Officer

Kevin Feely

Chief Financial Officer

Sibu Nnamdi

Analyst, Guggenheim

Bill Bonello

Analyst, Craig-Hallam

Kyle Mixon

Analyst, Canaccord Genuity

David Westenberg

Analyst, Piper Sandler

Dan Brennan

Analyst, TD Cowen

Tycho Peterson

Analyst, Jefferies

Keith Hinton

Analyst, Freedom Capital Markets

Brandon Couillard

Analyst, Wells Fargo

Mark Massaro

Analyst, BTIG

Replay transcript excerpt

Good day, and thank you for standing by. Welcome to the GeneDx Fourth Quarter 2025 Earnings Conference Call. At this time, all participants are in a listen-only mode. After the speaker's presentation, there will be a question and answer session. To ask a question during the session, you will need to press star 11 on your telephone. You will then hear an automated message advising your hand is raised. To withdraw your question, please press star 11 again. Please be advised that today's conference is being recorded. I would now like to hand the conference over to your speaker today, Sabrina Dunbar, Investor Relations. Please go ahead. Thank you, Operator, and thank you to everyone for joining us today. On the call, we have Catherine Stuland, President and Chief Executive Officer, and Kevin Feely, Chief Financial Officer. Earlier today, GDX released financial results for the fourth quarter, ended December 31, 2025. Before we begin, please take note of our cautionary statements. We may make forward-looking statements on today's call, including about our business plans, guidance, and outlook. Forward-looking statements inherently involve risks and uncertainties and only reflect our view as of today, February 23rd, and we're under no obligation to update. When discussing our results, we refer to non-GAAP measures, which exclude certain items from reported results. Please refer to our fourth quarter 2025 earnings release and slides available. at ir.gbx.com for definitions and reconciliations of non-GAAP measures and additional information regarding our results, including a discussion of factors that could cause actual results to materially differ from forward-looking statements. And with that, I'll turn the call over to Catherine. Thank you, Sabrina, and good morning, every...

More from Genedx Holdings Corp.